AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

MCK · NYSE · Medical - Distribution

McKesson (MCK)

Distributes medicines while powering specialty care, medication access, and pharmacy operations.

$891.23

After hours−0.66 (−0.07%)

At close$891.89(+0.61%)

In millions of USD, except per-share figures

In millions	Q2 FY24Sep 2023	Q3 FY24Dec 2023	Q4 FY24Mar 2024	Q1 FY25Jun 2024	Q2 FY25Sep 2024	Q3 FY25Dec 2024	Q4 FY25Mar 2025	Q1 FY26Jun 2025	Q2 FY26Sep 2025	Q3 FY26Dec 2025	Q4 FY26Mar 2026	Q1 FY27Jun 2026
Revenue	77,215	80,898	76,355	79,283	93,651	95,294	90,823	97,827	103,150	106,158	96,295	105,380
Cost of revenue	74,317	77,866	72,892	76,327	90,505	92,074	87,903	94,548	99,608	102,473	92,251	101,695
Gross profit	2,898	3,032	3,463	2,956	3,146	3,220	2,920	3,279	3,542	3,685	4,044	3,685
	2,000	2,409	2,091	1,895	2,401	1,933	1,884	2,243	2,074	2,066	1,796	2,366
	2,000	2,409	2,091	1,895	2,401	1,933	1,884	2,196	2,074	−2,030	1,796	2,264
Selling & marketing	0	0	0	0	0	0	0	2,196	2,074	−2,030	0	0
Other expenses	0	0	0	0	0	0	0	47	0	4,096	0	102
Operating income	898	623	1,372	1,061	745	1,287	1,036	1,036	1,468	1,619	2,248	1,319
	18	−11	−202	23	−211	−61	479	15	−73	11	−123	−11
Interest expense	61	64	80	66	78	67	45	49	74	63	−61	77
Other non-operating income	−79	−53	122	−89	133	−6	−524	−64	−1	−36	184	−66
Income before tax	916	612	1,170	1,084	534	1,226	1,515	1,051	1,395	1,630	2,125	1,308
Income tax expense	213	−18	340	124	247	298	209	220	232	380	270	276
Net income from continuing operations	703	630	830	960	287	928	1,306	831	1,163	1,250	1,855	1,032
Net income	664	589	791	915	241	879	1,260	784	1,110	1,186	1,682	614
EPS, basic	$4.95	$4.45	$6.05	$7.05	$1.87	$6.98	$10.06	$6.28	$8.95	$9.63	$13.78	$5.17
EPS, diluted	$4.93	$4.42	$6.01	$7.00	$1.86	$6.94	$10.01	$6.25	$8.92	$9.59	$13.71	$5.15
Weighted average shares, basic	134	133	131	130	129	126	125	125	124	123	122	119
Weighted average shares, diluted	135	133	132	131	129	127	126	126	124	124	123	119
EBITDA	1,134	835	1,410	1,319	775	1,446	1,711	1,257	1,657	1,843	2,260	1,385
Depreciation & amortization	157	159	160	169	163	153	151	157	188	188	196	0
EBIT	977	676	1,250	1,150	612	1,293	1,560	1,100	1,469	1,655	2,064	1,385